Four-week repeated oral dose toxicity study of zinc maltol in rats.


Journal

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
ISSN: 1873-6351
Titre abrégé: Food Chem Toxicol
Pays: England
ID NLM: 8207483

Informations de publication

Date de publication:
May 2023
Historique:
received: 30 11 2022
revised: 07 03 2023
accepted: 27 03 2023
medline: 11 4 2023
pubmed: 31 3 2023
entrez: 30 3 2023
Statut: ppublish

Résumé

Zinc (Zn) is one of the trace elements, and Zn deficiency causes many adverse effects. Zn complexes are used for Zn supplementation, but there are few toxicity reports. Zn maltol (ZM) was orally administered for 4 weeks to male rats at a dose of 0, 200, 600, or 1000 mg/kg to assess its toxicity. As a ligand group, maltol was administered at a dose of 800 mg/kg/day. General conditions, ophthalmology, hematology, blood biochemistry, urinalysis, organ weights, necropsy, histopathology, and plasma Zn concentration were investigated. Plasma Zn concentration increased with dose levels of ZM. The following toxicities were observed at 1000 mg/kg. Pancreatitis was observed with histopathological lesions and increases in white blood cell parameters and creatine kinase. Anemia was observed with changes in red blood cell parameters and extramedullary hematopoiesis in the spleen. Decreases in the trabecula and growth plate in the femur were observed. On the other hand, no toxicities were observed in the ligand group. In conclusion, these toxicities induced by ZM have been reported as Zn-related toxicities. It was considered that these results will be helpful for a creation and development of new Zn complexes as well as supplements.

Identifiants

pubmed: 36997052
pii: S0278-6915(23)00157-6
doi: 10.1016/j.fct.2023.113755
pii:
doi:

Substances chimiques

maltol 3A9RD92BS4
Zinc J41CSQ7QDS
Ligands 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113755

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Masaya Hitomi (M)

Department of Drug Safety Research, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10, Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. Electronic address: Hitomi.Masaya@otsuka.jp.

Fumika Akizawa (F)

Department of Drug Safety Research, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10, Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. Electronic address: Akizawa.Fumika@otsuka.jp.

Satoshi Kondo (S)

Department of Drug Safety Research, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10, Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. Electronic address: Kondo.Satoshi@otsuka.jp.

Koji Dogishi (K)

Department of Drug Safety Research, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10, Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. Electronic address: Dogishi.Koji@otsuka.jp.

Sakura Fujiwara (S)

Department of Drug Safety Research, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10, Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. Electronic address: Fujiwara.Sakura@otsuka.jp.

Hiroki Kimoto (H)

Department of Drug Safety Research, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10, Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. Electronic address: Kimoto.Hiroki@otsuka.jp.

Takayasu Moroki (T)

Department of Drug Safety Research, Tokushima Research Institute, Otsuka Pharmaceutical Co., Ltd., 463-10, Kagasuno, Kawauchi-cho, Tokushima, 771-0192, Japan. Electronic address: Moroki.Takayasu@otsuka.jp.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH